23 results

Vascepa, the fish-oil pill developed by Irish drug company Amarin last night failed to win the backing of US advisers to significantly expand its use (...)

Amarin investors are getting decidedly twitchy. And with good reason. The Irish company this week goes before a US Food and Drug Administration panel (...)

Amarin chief executive and chairman Joseph Zakrzewski. The company  saw its stock price tumble 8.4 per cent to $5.65 when the Nasdaq opened yesterday. Photograph: Cyril Byrne

Shares in Irish biopharma group Amarin fell sharply today after it announced plans for a sale of 21.7 million new shares in an underwritten public off(...)

  • « First
  • Prev
  • 1
  • 2
  • 3